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Although Marcello Malpighi in 1666 was the first to call
attention to the glomerulus as an important part of the mam-
malian kidney, it was not until the detailed microscopic obser-
vations of von Möllendorf and Zimmermann around 1930 that
the central or axial, connective tissue-like space of the glomer-
ular capillary tuft was distinguished from the glomerular endo.
thelial and epithelial cell layers. This inter- or pericapillary
region, harboring a "third cell" type, came to be known as the
mesangium and became a focus of investigative interest for
students of glomerular morphology, function and pathobiology
[reviewed in 1]. To pathologists and nephrologists, it has been
a most important finding that the expansion of the mesangium,
due to increases in cellularity and extracellular matrix, is a
prominent histologic abnormality in all types of chronic, pro-
gressive glomerular disease. The proliferative response in the
human mesangium is most pronounced in diseases such as
mesangiocapillary glomerulonephritis and IgA nephropathy.
The sclerotic response as characterized by the accumulation of
mesangial matrix, is a common feature of all advanced glomer-
ular lesions and is especially prominent in diabetic nephropathy
and chronic diseases such as focal and segmental glomerulo-
sclerosis. In view of the obvious involvement of the mesangium
in the pathogenesis of glomerular disease, it is important to
understand the mechanisms which control the behavior of
mesangial cells under physiological and abnormal conditions.
The mesangium is a highly specialized, branching pericapil-
lary tissue which is composed of the intrinsic, vascular smooth
muscle cell-like mesangial cells, very rare resident Ia antigen-
bearing cells and transient monocyte-macrophages surrounded
by an extracellular matrix. Although the exact composition of
the mesangial matrix is not known, immunohistochemical and
biochemical studies have demonstrated that, in the normal
state, major components include collagens IV and V, fibronec-
tin, laminin, entactin/nidogen and proteoglycans such as chon-
droitin sulfate and heparan sulfate proteoglycans. The fine
structural relationship of the mesangium to the rest of the
glomerulus was originally described by Latta and by Farquhar
and has more recently been reinterpreted by Kriz et al [2].
These studies have demonstrated the importance of the cell-
matrix relationships in terms of structural support and have
suggested modulation of the glomerular microcirculation
through mesangial cell contraction. Because of its close contact
to the glomerular capillary lumen via the fenestrated endothe-
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hum, the mesangium is constantly perfused by macromolecules
and filtration residues. These may accumulate in the matrix or
be taken up by mesangial cells by endocytosis. This process can
be of particular importance if the filtration residues include
phiogogenic immune complexes or circulating cytokines and
growth factors which may activate mesangial cells to proliferate
and change their secretory phenotype, for example, with re-
spect to the production of matrix. The determinants of mesan-
gial entry, uptake and removal of macromolecules have been
examined in detail by several investigators and have been
previously reviewed [3].
Recent studies of renal tissue and isolated glomeruli have
shown that mesangial cells are capable of producing several
peptide cytokines and growth factors, as shown by use of
specific antibodies and cDNA probes [reviewed in 4]. These
findings, which are supported by many cell culture data, indi-
cate that mesangial cells can actively participate in the inflam-
matory response to glomerular injury, for example, by secreting
paracrine or autocrine factors. These products could mediate
interactions with glomerular endothelial and epithehial cells and
blood-borne inflammatory cells.
In addition to the matrix components seen in the normal
glomerulus, the interstitial collagens I and III have been local-
ized in a variety of glomerular diseases [1, 4—6]. They are
thought to be produced primarily by mesangial cells. It is
remarkable that the rather uniform glomerulosclerosis seen in
different diseases can result from a variety of seemingly unre-
lated injurious stimuli. Importantly, this process of tissue
remodeling leading to mesangial expansion and glomerular
scarring appears to progress independently of the type of
glomerular injury, even after termination of the initial stimulus.
The nature of this perpetuating process is at present poorly
understood.
An obvious question is: what physiologic or abnormal factors
control and affect mesangial cell proliferation and differentia-
tion, matrix production and secretion of autocrine and para-
crine mediators? In order to maintain normal structure and
function of the mesangium and, thus, of the glomerular capillary
tuft, the proliferative and secretory activities of mesangial cells
must be tightly regulated in vivo. Several regulatory mecha-
nisms, involving signals from multiple exogenous and cellular
mediators, have been identified. During acute injury, the
mesangium has the capability of interacting with inflammatory
cells, which could result in the disturbed integration of the
complex regulatory events controling mesangial cell prolifera-
tion and secretion, for example, from a loss of homeostatic
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feedback mechanisms. The development of techniques for in
vitro culture of mesangial cells has permitted a detailed exam-
ination of some of the cellular and molecular mechanisms which
may be involved in processes relevant to glomerular injury, the
inflammatory response and glomerular "wound healing." Re-
lying mostly on results from cell culture studies, this brief
review will focus on aspects of mesangial cell proliferation and
secretion of soluble mediators and matrix components. It will
include a discussion of the available data on autocrine effects of
mesangial cell products and on interactions between mesangial
matrix and cells. The structural and functional involvement of
the mesangium in the maintenance and pathophysiology of the
glomerular capillary microcirculation has been reviewed else-
where [7, 8] and will not be discussed here.
Mesangial cell proliferation
A large number of mediators have been implicated as mesan-
gial cell mitogens [1, 4]. They include a variety of cytokines,
growth factors and autacoids as well as hormones, Several
substances are secreted not only by inflammatory cells and
neighboring endothelial cells but also by mesangial cells them-
selves. Therefore, these factors can act either in a paracrine or
autocrine fashion. Included are PDGF, one of the main biolog-
ical mediators present in a granules of platelets which is also
produced by monocytes and macrophages, as well as mesen-
chymal cells such as endothelial cells; EGF which is also
present in a granules of platelets; tumor necrosis factor-a
(TNF-a), a protein produced by activated macrophages; inter-
leukin-l (IL-l), a classic macrophage cytokine, as well as IL-6
and IL-8. Endothelin, a potent peptide vasoconstrictor pro-
duced by endothelial and mesangial cells, has recently been
added to this list of paracrine-autocrine mesangial cell mito-
gens. A number of other mediators have also been implicated as
mitogens or comitogens. These include insulin-like growth
factor I (IGF1), growth hormone, basic fibroblast growth factor
(bFGF), arginine vasopressin, serotonin, thromboxane and
ATP.
Mesangial cells in two-dimensional culture show significantly
different responses to various growth factors, both in terms of
the time course and the magnitude of the mitogenic effect. In
addition, many such mediators require the presence of small
amounts of serum to demonstrate any significant growth-pro-
moting activity. These observations suggest that growth factor
effects depend on cell cycle. Some mitogens have been shown
to be competence factors which allow the cell to advance from
G0 to G1 and thereby set the stage for progression of the
mitogenic event. These include PDGF, bFGF and IL-6. Al-
though specific matrix components themselves may not func-
tion in an identical way, they can accelerate or reduce the
proliferative effects of cytokines. Progression factors which
carry the cell cycle beyond G1 through mitosis are thought to
include IGF-l, EGF and IL-I. All of these stimulate DNA
synthesis in PDGF-primed cells. Assessment of the prolifera-
tive effects is further complicated by the fact that these same
growth factors may also stimulate production of autocrine
growth modulators by the mesangial cell. A comparison of the
effects of IL-6 with those of PDGF demonstrates these differ-
ences. Studies in our laboratory examining the incorporation of
the thymidine analogue BRD[J by cultured mesangial cells
demonstrated that IL-6 has a potent mitogenic effect within 24
hours in the presence of 0.5% serum. PDGF in the absence of
serum induces only a modest BRDU incorporation at 24 hours,
but has a strikingly more potent effect by 48 hours (Kashgarian,
unpublished data). These observations suggest that within the
first 24 hours, PDGF is acting as a competence factor, and that
its secondary mitogenic response may be related to autocrine
stimulation of growth factors acting as progression factors and
resulting in the more vigorous later response.
Recent work from Marx and Madri has demonstrated that the
PDGF isoforms involved are also important (reported in this
issue). PDGF-BB is a more potent mitogen than PDGF-AB, and
PDGF-AA given exogenously has no significant mitogenic
effect on cultured mesangial cells. The difference was found to
be due to the variable surface expression of the specific PDGF
receptors. It appears to be of major importance that the
mitogenic response to a cytokine is further modulated by the
matrix on or in which the mesangial cells are grown. Cells
grown on a matrix containing fibronectin or collagen IV show
greater stimulation of DNA synthesis than cells grown on
collagen I or laminin. The differences in mesangial cell response
to cytokine isoforms, for example, IL-lf.3 and IL-la, are also
altered by the underlying matrix composition. Thus, it appears
that, in vitro, there are multiple factors which may modify the
mitogenic response of cultured mesangial cells to a given
growth modulator. They include the state of the cell cycle, the
density of surface receptors, autocrine secretion of growth
factors and modulation by composition and organization of the
surrounding matrix.
Inhibitors of mesangial cell proliferation
In view of the fact that, in vivo, mesangial cells have very low
rates of growth and turnover, paracrine or autocrine effects of
peptides or other factors which act as inhibitors of mesangial
cell proliferation may be operative. The substances which have
been demonstrated to inhibit mesangial cell proliferation in
vitro include TGF-13, atrial natriuretic factor, endothelial cell-
derived relaxing factor (EDRF) or its NO products, heparin,
heparansulfate proteoglycan and high glucose concentration.
The growth factor which has recently received much attention
as a powerful growth modulator is TGF-/3 (A. Roberts, this
issue; [4, 9]). TGF-J3 is a 25 kD homodimer peptide found in
high concentrations in macrophages as well as in platelets, and
is synthesized by numerous cell types including the mesangial
cell, TGF-/3 has been demonstrated to be a bifunctional regu-
lator of mesangial cell proliferation in vitro and is considered to
be a differentiating growth factor. Mesangial cells contain high
affinity receptors for TGF-/3. It has been shown that TGF-/3 is a
potent inhibitor of the stimulation of cell proliferation induced
by PDGF, IGF1 and EGF. It is of interest, however, that the
inhibitory effect is seen primarily in cells actively proliferating
in low density. High density confluent mouse mesangial cell
monolayers actually show a stimulation of proliferation by
TGF-13. Similarly, the effect of TGF-/3 on EGF induced mito-
genesis appears to be biphasic, with low doses of TGF-13
stimulating the mitogenic effect of EGF and high doses inhibit-
ing it. Work from our laboratory has demonstrated that in the
absence of other growth factors and serum, TGF-p neither
stimulates nor inhibits the constitutively low proliferative rate
of cultured mesangial cell under these conditions (Kashgarian,
unpublished observations).
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Most culture studies of mesangial cell mitogenic responses
are carried out in medium containing 25 m glucose. This is
considerably higher than under normal physiologic conditions
and can actually be considered equivalent to pronounced hy-
perglycemia in vivo. Recent studies from our laboratory have
examined the effect of varying glucose concentration on the
mitogenic response of mesangial cells (Kashgarian, unpublished
observations). We found that cells have a much more vigorous
mitogenic response in the presence of physiological concentra-
tions of glucose in the range of 5 mi. Increasing concentrations
of medium glucose to 15 m and 25 m showed inhibitory
effects with as much as a 50% decrease in the mitogenic
response at 25 mrvi extracellular glucose concentration. It is of
interest that the decreased mitogenic response is accompanied
by significant cellular hypertrophy, a prominent feature of
glomerular cells in experimental models of diabetes mellitus.
The cellular hypertrophy was characterized by both an increase
in cell size and an increase in the RNA-DNA ratio.
Autocrine regulation of cytokine secretion
Of major importance for the regulation of mesangial cell
proliferation is the fact that mesangial cells themselves produce
growth factors and cytokines with autocrine potential [1, 4]. In
a recent study by Silver, Jaffer and Abboud [10], mesangial cell
secretion of PDGF was found to be stimulated by a wide variety
of growth factors including PDGF itself, PDGF mRNA and
secretion of protein were increased by serum, EGF, TGF-a,
TGF-f3, TNF-a and FGF. Moreover, Jaffer et al [11] have
demonstrated that endothelin stimulates PDGF production by
mesangial cells. Autocrine secretion may well explain the
delayed mitogenic response seen with PDGF, in which the
initial effect of PDGF at 24 hours may be that of a competence
factor and the brisk mitogenic effect at 48 hours produced by
stimulation of autocrine secretion and action of a progression
factor. Earlier studies by Lovett and Larson [12] have demon-
strated that mesangial cell secretion of IL-I is stimulated by
PDGF and EGF, and Ruef et al [13] have reported that
autocrine IL-6 secretion is under similar control. It is obvious
that the stimulation or suppression of expression and secretion
of mitogenic factors by the mesangial cell as induced by other
soluble or insoluble growth modulators complicates the inter-
pretation of specific effects of various growth factors in this
system.
Matrix modulation of mesangial cell behavior
It is now clear that composition and spatial organization of
matrix play an important role in modulating the proliferative
response and the secretory activities of many cell types, includ-
ing mesangial cells. Matrix components exert specific non-
diffusable signals to cells at a microenvironmental level, thus
providing the specific solid-phase context in which the cell
behavior is regulated by many exogenous dift'usable signals,
such as cytokines and autacoids [14]. The question remains
open how the matrix affects the mesangial cell phenotype.
Mesangial cells, when grown in long term culture, form hillocks
which are large nodules of mesangial cells embedded in matrix.
In contrast to the usual two-dimensional arrangement of mesan-
gial cell outgrowth in short term culture, mesangial cells in
hillocks appear to utilize a self-made three-dimensional matrix
support which is akin to the in vivo situation [151. Mesangial
cells in hillocks demonstrate two morphologic phenotypes,
fusiform and elongated in the periphery of the hillock and
stellate, plump in the center. The two phenotypes also show
functional differences. The fusiform cells demonstrate a striking
increase in the proliferative rate following stimulation with FCS
while the stellate cells have only a very modest growth response
(Grond, Sterzel and Kashgarian, manuscript in press).
Since the system of three-dimensional mesangial cell culture
is perhaps a closer in vitro approximation of the pathologic
processes which occur in vivo, it is of interest to examine other
mesangial cell functions under these circumstances. Studies by
Ruef and coworkers (D. Coleman, unpublished data) have
demonstrated that the PDGF stimulation of IL-6 secretion by
mesangial cells is inhibited when cells are grown in a three-
dimensional culture composed of collagen I. This was not seen
for the stimulation of IL-6 secretion initiated by the growth
factor cocktail present in 10% FCS, and was not observed when
cells were grown in matngel. The decrease in mitogenic re-
sponse to PDGF and the decrease in PDGF stimulation of IL-6
production is likely related to the observation by Marx and
Madri (reported in this issue) that three-dimensional culture
results in a striking down-regulation of the PDGF-13 receptor
expression on the mesangial cell surface. Alterations of the
morphologic phenotype and differentiation of mesangial cells,
caused by matrix composition, may affect mesangial cell secre-
tion of matrix, as well. For example, we observed that the
peripheral fusiform phenotype of mesangial cell hillocks se-
cretes predominantly basement membrane components such as
fibronectin, laminin and collagen IV. The central stellate and
more differentiated phenotype appears to secrete larger
amounts of these components as well as secreting interstitial
collagens I and III [151. When we culture mesangial cells in a
pure collagen I gel, they appear to preferentially secrete and
incorporate fibronectin and collagen III into the collagen I
matrix, whereas collagen IV secretion is down-regulated (Ish-
imura et al, unpublished observations).
What are the molecular mechanisms allowing such multiple
and specific interactions between matrix and cells? Numerous
cell types have been shown to express transmembraneous
surface glycoproteins that specifically interact with matrix
components. The widely distributed integrins, a protein super-
family, seem to play a key role in specific cellular recognition of
and adhesion to matrix components (reviewed by K. von der
Mark, S. Goodman and M. Korhonen in this issue).
First immunochemical studies of the f3 series of integrins in
normal human kidney tissue have revealed that the cells of the
human and rat glomerulus express a1-, a2- and a.3-f31 het-
erodimers, proteins that in other cell types bind to laminin,
fibronectin and collagens I, II and 1V (M. Korhonen, this issue;
[16, 17]). Their specificity in the glomerulus is presently uncer-
tain. By contrast, the a4f31 and a5f31 fibronectin receptors and
the a6f31 laminin receptor were not detected in glomeruli. In
kidney sections, antibodies to the al subunit are most strongly
localized to the mesangium. Cosio, Sedmak and Nahinan [16]
have demonstrated that cultured human mesangial cells express
a1, a3 and a51 integrins. In addition to the a1, a3 and a5
subunits, we found a2 but not a6 used by mesangial cells in focal
contacts with the matrix substratum (Grenz et al, unpublished
observations). Marx and Madri have also demonstrated the
presence of p3 integrins on mesangial cells (unpublished data).
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Mesangial cell attachment appears to be mediated through these
integrin receptors since antibodies to a5 and RGD peptides
inhibited mesangial cell binding to fibronectin [161. Similar
specific cell-matrix interactions may also mediate the heparin-
induced inhibition of mesangial cell proliferation [4]. The bio-
logical relevance of these early findings on mesangial cell
integrins is as yet unknown. Much work is needed to elucidate
the mechanisms involved in matrix-induced signal transduction
resulting in changes of mesangial cell behavior. It is clear that
the use of three-dimensional culturing of mesangial cells or tests
in intact organs are needed to address these questions in a more
comprehensive fashion since composition as well as architec-
ture of the matrix may provide signals to the cell.
Interestingly, matrix signals also play an important part in the
regulation of the synthesis of matrix components by mesangial
cells. We have recently demonstrated that the production of
matrix components parallels mesangial cell growth and that
secretion and extracellular deposition of matrix components
occurs at cell to cell contact [18]. The production of laminin and
collagen IV and their incorporation into the substratum by
mesangial cells accelerated the synthesis and facilitated the
secretion of other extracellular components in an autocrine
fashion. Extracellular organization of collagens IV and laminin
into a matrix was associated with a down regulation of their
gene expression and synthesis of mesangial cells. This relation-
ship, suggesting a negative feedback, was not observed for
collagen I and III. These results are consistant with the notion
that in pathologic states when interstitial collagens are present
within the glomerulus, their production may not be normally
down regulated, and that the presence of interstitial collagens
may be a stimulus to persistent secretion of matrix components
by mesangial cells leading to glomerular sclerosis.
Since the overproduction of matrix is a characteristic of
diabetic glomerulosclerosis, it is of importance to understand
how hyperglycemia may induce alterations in mesangial cell
biology which could affect matrix synthesis, composition and
secretion. Studies by Ayo et al [19] as well as from our
laboratory have demonstrated that "hyperglycemic" culture
conditions with glucose concentrations in the range of 25 mM
increase the secretion of collagens and other matrix compo-
nents by mesangial cells. We observed that the increased
secretion is accompanied by increased mRNA expression for
collagen IV and collagen I, but not for collagen III (Kashgarian,
unpublished data). Our preliminary studies indicated that the
increased mRNA expression is not due to greater mRNA
stability but rather to increased transcription. This response
was associated with a rise in the RNA-DNA ratio, suggesting
that cellular hypertrophy with stimulation of RNA synthesis
and relative inhibition of DNA synthesis may be the molecular
mechanism involved.
As mentioned above, TGF-p is a potent inhibitor of DNA
synthesis in mesangial cells [4, 9, 20]. While the exact mecha-
nisms involved in this effect are presently unclear, there are
data to suggest that some of TGF-/3's actions are mediated
through regulatory effects on the turnover of extracellular
matrix. For example, work of Okuda et al has implicated a
potential role for TGF-J3 in abnormal secretion of matrix in
experimental glomerulonephritis [21]. Studies in our laboratory
have demonstrated that TGF-/3 modulates the synthesis of
individual extracellular matrix components differently, both at
the level of gene expression and protein synthesis (Ishimura et
al, unpublished data). There is a specific stimulatory effect of
TGF-/3 on collagen IV and laminin, both at the mRNA and
protein level. No specific change was seen for collagen I and
collagen III, suggesting that TGF-/3 can act as a differentiating
growth factor which modulates mesangial cells from a prolifer-
ative to a more differentiated secretory phenotype. The simi-
larity of the responses of cultured mesangial cells to high
glucose and to TGF-p suggests the possibility that autocrine
mechanisms, perhaps involving TGF-13, could be operative in
the process of diabetic glomerulosclerosis. Clearly, much work
is needed to specify the likely role of TGF-/3 in mesangial matrix
accumulation and its relationship to effects on mesangial cell
growth.
Matrix removal
The control of the amount of deposited mesangial matrix and,
thus, of glomerular sclerosis occurs not only at the level of
matrix formation but also of extracellular degradation. Mesan-
gial cells produce several neutral proteases as well as tissue
inhibitors of proteases (reviewed by M. Davies in this issue).
Both types of biologic activity are assumed to play an important
role in mesangial remodeling and may provide control mecha-
nisms for maintaining normal amounts of matrix within the
mesangium. Studies from our laboratories have demonstrated
that IL-i as well as TGF-/3 specifically stimulate the production
and secretion of a neutral protease into the supernate of
cultured mesangial cells (Lovett and Kashgarian, unpublished
data). The increase in secretion induced by TGF-/3 is accompa-
nied by an increase in protease mRNA expression. The activity
of a tissue inhibitor of metalloprotease (TIMP) is not specifi-
cally affected by TGF-f3. However, TIMP appears to be stim-
ulated in mesangial cells when increased amounts of neutral
protease are present in the medium. The complex mechanisms
of the neutral protease enzyme and inhibitor system as well as
its regulation and potential contributory role in the process of
glomerulosclerosis must be elucidated further.
Signal transduction
The behavior of mesangial cells is affected and regulated by
multiple soluble and diffusable as well as solid phase, non-
diffusable signaling molecules. Their ligation to specific mem-
brane receptors triggers the activation of second messengers
which induce short-term signals and cellular responses. These
may be coupled by transcription factors to long-term processes
involving alteration of gene expression and protein synthesis,
ultimately leading to specific changes of the cellular phenotype.
The multiplicity of agonists and inhibitors which—individually
or simultaneously—affect mesangial cell behavior compounds
the problem of sorting the specific regulatory signals and
mechanisms. Numerous investigators have attempted to define
the cellular mediators of mesangial cell responses and a wide
variety of potential signaling networks and mechanisms have
been identified. Important messenger systems include: the U
proteins, which are coupled to both inhibitory and stimulatory
effectors in the cytosol; phospholipases C, D and A2; various
isoforms of protein kinase C; protein kinase A; activation of ion
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channels, transporters and exchangers; stimulation of sodium
potassium ATPase and release of intracellular calcium. Also,
arachidonic acid metabolites have been studied and implicated
both as potential signal transduction messengers and as effec-
tors themselves (reviewed in this issue by M. Simonson et al; V.
Sukhatme; P. Menè). This exciting research has revealed first
information on how these ligand-induced cellular signals induce
specific changes of the genetic program in the mesangial cell
nucleus which direct the phenotypic response.
Animal models of mesangial cell injury
A crucial question is whether or not these in vitro character-
istics of mesangial cell biology play an important role in
glomerular disease. As recently reviewed by Striker et al [4],
various experimental disease models have been studied, includ-
ing transgenic mice, rat models of glomerulonephritis (such as,
anti-Thy 1 and anti-glomerular basement membrane types),
puromycin-induced nephrosis, and diabetic animal models. For
example, mesangial pathology was observed in a transgenic
mouse model in which the entire early portion of the SV4O
genome containing the T-antigen was overexpressed and was
associated with glomerulosclerosis [221. Doi et al have demon-
strated that overexpression of growth hormone, but not of
IGF1, also results in a transgenic mouse model in which
glomeruloscierosis progresses rapidly [23]. Finally, Suematsu
et al have reported that mice transgenic for IL-6 develop a
proliferative glomerulonephritis associated with widespread
IgGI plasmacytosis [24]. Reproducible and well-studied rat
models of glomerular disease include anti-Thy 1 glomerulone-
phritis. Work by Border et al has demonstrated that TGF-/3 may
play an important role in the development of glomerular lesions
seen in this model since TGF-/3 blocking antibodies reduced the
proliferative response in the mesangium [25]. Johnson et al have
demonstrated that platelet depletion decreased the hypercellu-
lar response in anti-Thy I glomerulonephritis and that comple-
ment depletion reduced platelet accumulation and glomerular
cell proliferation [26]. More recently, this group has demon-
strated that PDGF and PDGF receptor /3-subunit RNAs are
increased in the glomeruli of the anti-Thy I glomerulonephritic
rat and that this is diminished by platelet and complement
depletion (R. Johnson, this issue). These studies support the
concept, developed on the basis of mesangial cell culture
findings, that PDGF promotes the proliferative and sclerotic
responses in the mesangium. Nakamura et al have reported that
increased mRNA expression for matrix components is stimu-
lated in glomeruli of rats with puromycin nephrosis, demon-
strating a role for enhanced mesangial matrix production in the
process of glomerulosclerosis [27]. Similarly, Abrass and co-
workers have observed that the phenotypic expression of
collagen types in the mesangial matrix of diabetic rats is altered
showing increased expression of interstitial collagens [5]. Fur-
thermore, Merrit et al have reported that mRNAs for collagen I
and IV obtained from renal cortex showed a greater increase at
an earlier time point than these mRNAs in isolated glomeruli of
rabbits with experimental anti-glomerular basement membrane
disease [28]. These findings suggest that increased extraglom-
erular matrix production when associated with intraglomerular
inflammation may be related to glomerular synthesis and secre-
tion of cytokines. These somehow reach the tubulointerstitial
space where they exert fibrogenic effects. Experimental testing
of this hypothesis will help to clarify the common association of
interstitial fibrosis with glomerulonephritis.
There are numerous complex and as yet largely unclear
effects of cytokines and matrix on the regulation of mesangial
cell behavior, in vivo and in vitro. The available evidence from
animal experiments supports the concept that aberrations of
these specific regulatory mechanisms play an important con-
tributory role in the development of chronic glomerular disease.
Thus, whether it be diabetic glomerulosclerosis, hypertension-
induced nephrosclerosis or immune-mediated glomerulonephri-
tis, the long-term abnormalities of the mesangium are likely to
involve alterations in mesangial cell-matrix interaction. We
postulate that this results in extended changes of the mesangial
cell phenotype with altered production of cytokines and matrix.
In an autoregulatory fashion, these soluble and insoluble signals
may contribute to persistent mesangial cell proliferation and,
most importantly, to matrix accumulation leading to progres-
sive glomerulosclerosis.
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